bioRxivBiophysicsPreprint
Low-order MLKL oligomers induce irregular membrane defects in necroptosis
Veronica Martinez-Osorio, Qingrong Zhang, Silvia Zanna, Jonas AufdermaueriD, Uris RosiD, Ana J. García-Sáez
Abstract
MLKL is a key executioner of necroptosis, a lytic form of regulated cell death associated with inflammatory pathologies. Upon activation by RIPK3-mediated phosphorylation, MLKL oligomerizes and translocates to the plasma membrane to induce permeabilization through yet unknown mechanisms. By imaging single particles of MLKL at the plasma membrane of necroptotic cells, here we show that, upon activation, MLKL transitions from a diffuse cytosolic distribution to discrete, low-mobility assemblies before cell bursting. This is accompanied by oligomerization into a mixture of species ranging from monomers up to hexamers. We directly visualize MLKL-induced membrane damage using atomic force microscopy imaging in supported bilayers, which reveals the formation of irregular membrane openings whose edges are only partially decorated with protein. Our findings support a mechanism in which low-order self-assemblies of MLKL disrupt plasma membrane integrity and stabilize membrane defect edges without organizing into defined pore structures, in contrast to membrane permeabilization in other forms of cell death. This reframes necroptosis execution and dissects membrane insertion of MLKL oligomers for potential targeting.
- assay: imaging
- research focus: cell-cell communication
- research focus: spatial domain detection
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Oligomerization-driven MLKL ubiquitylation antagonises necroptosis
Zikou Liu, Laura F. Dagley, … John Silke·bioRxiv·May 1, 2021
- Lysosomal MLKL is balanced by ESCRT to control cell death
- Membrane permeabilization is mediated by distinct epitopes in mouse and human orthologs of the necroptosis effector, MLKL
A. Sethi, C. R. Horne, … J. M. Murphy·bioRxiv·May 3, 2021
- Mechanistic Insights into MLKL Activation via Allosteric Pathways Identified Through Molecular Models
Ricardo X. Ramirez, Viviana Monje‐Galvan·bioRxiv·Jun 11, 2026
- Species-specific LUBAC-mediated M1 ubiquitination regulates necroptosis by segregating the cellular distribution and fate of activated MLKL
N. Weinelt, K. N. Waechtershaeuser, … S. J. L. van Wijk·bioRxiv·Dec 8, 2022
- Acylation of MLKL impacts its function in necroptosis
A. J. Pradhan, S. Chitkara, … G. E. Atilla-Gokcumen·ACS Chemical BiologyPeer-reviewed·Feb 1, 2024